首页> Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions> Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.

Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ajay J,Kirtane

第一单位： NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.;Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

作者： Ajay J,Kirtane ^[1] ; Alan C,Yeung ^[2] ; Michael,Ball ^[3] ; Jeffrey,Carr ^[4] ; Charles,O'Shaughnessy ^[5] ; Laura,Mauri ^[6] ; Minglei,Liu ^[7] ; Martin B,Leon ^[1]

作者单位： NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.;Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. ^[1] Stanford University School of Medicine, Stanford, California. ^[2] EMH Elyria Medical Center, Elyria, Ohio. ^[3] Tyler Cardiac and Endovascular Center and East Texas Medical Center, Tyler, Texas. ^[4] Saint Vincent Heart Center of Indiana, Indianapolis, Indiana. ^[5] Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. ^[6] Medtronic PLC, Santa Rosa, California. ^[7]

关键词 Resolute US Resolute zotarolimus-eluting stent drug-eluting stent percutaneous coronary interventions